Literature DB >> 34905091

Actin Polymerization Is Required for Filopodia Formation Supporting HSV-1 Entry into Activated T Cells.

Thanayod Sasivimolrattana1,2, Pokrath Hansasuta3, Supang Maneesri Le Grand4, Parvapan Bhattarakosol5,6.   

Abstract

Enhanced HSV-1 production is found in activated T-lymphocytes, but the mechanism is still unknown. In this paper, the HSV-1 entry step in CD3+CD4-CD8-Jurkat T lymphocytes was investigated. Observation under electron microscopy revealed the level of filopodia formation on the surface of activated Jurkat cells was significantly higher than that of non-activated Jurkat cells especially after adding HSV-1 for 15 min. A significant increase of actin protein was demonstrated in HSV-1 infected, activated Jurkat cells compared to HSV-1 infected, non-activated Jurkat cells. After the cells were treated with 2.5 and 5 µg/mL cytochalasin D, an inhibitor of actin polymerization that causes depolymerization of actin's filamentous form, the actin protein was decreased significantly, resulting in an absence of filopodia formation. In summary, this is the first study revealing that HSV-1 induced filopodia formation through actin polymerization in activated T cells similar to epithelial, mucosal and neuronal cells. This phenomenon supported the virus entry resulting to increased yield of HSV-1 production.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34905091     DOI: 10.1007/s00284-021-02716-1

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  22 in total

1.  Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.

Authors:  Anthony V Nicola; Stephen E Straus
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Battling the spread: Herpes simplex virus and encephalitis.

Authors:  Christina M Slifer; Stephen R Jennings
Journal:  Immunol Cell Biol       Date:  2015-08-11       Impact factor: 5.126

3.  A role for heparan sulfate in viral surfing.

Authors:  Myung-Jin Oh; Jihan Akhtar; Prashant Desai; Deepak Shukla
Journal:  Biochem Biophys Res Commun       Date:  2009-11-10       Impact factor: 3.575

4.  Herpes simplex virus type 1 induces filopodia in differentiated P19 neural cells to facilitate viral spread.

Authors:  Rohan Dixit; Vaibhav Tiwari; Deepak Shukla
Journal:  Neurosci Lett       Date:  2008-05-15       Impact factor: 3.046

5.  Increased susceptibility of herpes simplex virus-1 growth in phytohemagglutinin-activated T lymphocytes caused by upregulation of herpesvirus entry mediator A mRNA expression.

Authors:  Phattamawan Chimma; Chintana Chirathaworn; Parvapan Bhattarakosol
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

6.  Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry.

Authors:  Vaibhav Tiwari; Deepak Shukla
Journal:  J Gen Virol       Date:  2010-09-01       Impact factor: 3.891

Review 7.  Actin in herpesvirus infection.

Authors:  Kari L Roberts; Joel D Baines
Journal:  Viruses       Date:  2011-04-12       Impact factor: 5.048

8.  A novel role for phagocytosis-like uptake in herpes simplex virus entry.

Authors:  Christian Clement; Vaibhav Tiwari; Perry M Scanlan; Tibor Valyi-Nagy; Beatrice Y J T Yue; Deepak Shukla
Journal:  J Cell Biol       Date:  2006-09-25       Impact factor: 10.539

Review 9.  Filopodia and Viruses: An Analysis of Membrane Processes in Entry Mechanisms.

Authors:  Kenneth Chang; John Baginski; Samer F Hassan; Michael Volin; Deepak Shukla; Vaibhav Tiwari
Journal:  Front Microbiol       Date:  2016-03-10       Impact factor: 5.640

10.  Liposome-Mediated Herpes Simplex Virus Uptake Is Glycoprotein-D Receptor-Independent but Requires Heparan Sulfate.

Authors:  Lorrie A Burnham; Dinesh Jaishankar; Jeffrey M Thompson; Kevin S Jones; Deepak Shukla; Vaibhav Tiwari
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.